This inventor holds 6 USPTO granted patents and 6 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Parsa Akbari: Innovator in Liver Disease and Obesity Treatment
Introduction
Parsa Akbari is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the fields of obesity treatment and liver disease management. With a total of 6 patents to his name, Akbari's work is paving the way for innovative therapeutic approaches.
Latest Patents
Among his latest patents, Akbari has developed methods for treating obesity using G-Protein Coupled Receptor 75 (GPR75) inhibitors. Additionally, he has created methods for treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors. These patents also include methods for identifying subjects at an increased risk of developing liver disease or type 2 diabetes.
Career Highlights
Parsa Akbari is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work is instrumental in developing new treatments that could significantly improve patient outcomes in the areas of obesity and liver diseases.
Collaborations
Some of his notable coworkers include Luca Andrea Lotta and Aris I Baras. Their collaborative efforts contribute to the innovative environment at Regeneron Pharmaceuticals.
Conclusion
Parsa Akbari's contributions to medical science through his patents and research are noteworthy. His work in treating obesity and liver diseases showcases the potential for innovation in healthcare.